Correlation Between Tscan Therapeutics and Sellas Life
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Sellas Life Sciences, you can compare the effects of market volatilities on Tscan Therapeutics and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Sellas Life.
Diversification Opportunities for Tscan Therapeutics and Sellas Life
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tscan and Sellas is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Sellas Life go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Sellas Life
Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Sellas Life. In addition to that, Tscan Therapeutics is 1.12 times more volatile than Sellas Life Sciences. It trades about -0.24 of its total potential returns per unit of risk. Sellas Life Sciences is currently generating about 0.12 per unit of volatility. If you would invest 112.00 in Sellas Life Sciences on August 24, 2024 and sell it today you would earn a total of 10.00 from holding Sellas Life Sciences or generate 8.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Sellas Life Sciences
Performance |
| Timeline |
| Tscan Therapeutics |
| Sellas Life Sciences |
Tscan Therapeutics and Sellas Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Sellas Life
The main advantage of trading using opposite Tscan Therapeutics and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.| Tscan Therapeutics vs. ZyVersa Therapeutics | Tscan Therapeutics vs. Sonnet Biotherapeutics Holdings | Tscan Therapeutics vs. Zura Bio Limited | Tscan Therapeutics vs. Phio Pharmaceuticals Corp |
| Sellas Life vs. ZyVersa Therapeutics | Sellas Life vs. Sonnet Biotherapeutics Holdings | Sellas Life vs. Zura Bio Limited | Sellas Life vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |